159 related articles for article (PubMed ID: 12912793)
1. Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy.
Sader S; Nian M; Liu P
Circulation; 2003 Aug; 108(6):644-6. PubMed ID: 12912793
[No Abstract] [Full Text] [Related]
2. Leptin and the clinical cardiovascular risk.
Singh M; Bedi US; Singh PP; Arora R; Khosla S
Int J Cardiol; 2010 Apr; 140(3):266-71. PubMed ID: 19944469
[TBL] [Abstract][Full Text] [Related]
3. [The polycystic ovary syndrome--metabolic consequences].
Tan S; Hahn S; Janssen OE
Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
[No Abstract] [Full Text] [Related]
4. Leptin signaling and obesity: cardiovascular consequences.
Yang R; Barouch LA
Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
[TBL] [Abstract][Full Text] [Related]
5. Leptin resistance and obesity.
Enriori PJ; Evans AE; Sinnayah P; Cowley MA
Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():254S-258S. PubMed ID: 17021377
[TBL] [Abstract][Full Text] [Related]
6. [Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system].
Maisch B
Herz; 2006 May; 31(3):185-8. PubMed ID: 16770553
[No Abstract] [Full Text] [Related]
7. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?
Napoleone E; DI Santo A; Amore C; Baccante G; di Febbo C; Porreca E; de Gaetano G; Donati MB; Lorenzet R
J Thromb Haemost; 2007 Jul; 5(7):1462-8. PubMed ID: 17425664
[TBL] [Abstract][Full Text] [Related]
8. [Obesity related complications in children and adolescents].
Fichna P; Skowrońska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
[TBL] [Abstract][Full Text] [Related]
9. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.
Chua SC; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E384-92. PubMed ID: 14600075
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular hypertrophy - current views on the pathophysiology, association with cardiovascular risk, and therapeutic options].
Rostoff P; Gackowski A; Nessler J; Piwowarska W
Kardiol Pol; 2010 Jul; 68(7):815-23. PubMed ID: 20648446
[No Abstract] [Full Text] [Related]
11. Partial least squares analysis of the association between metabolic factors and left ventricular mass among Taiwanese adolescents.
Chien KL; Tu YK; Hsu HC; Su TC; Lee YT; Chen MF
Int J Cardiol; 2011 Mar; 147(2):305-6. PubMed ID: 21239071
[No Abstract] [Full Text] [Related]
12. Leptin: obesity, diabetes and other peripheral effects--a review.
Moran O; Phillip M
Pediatr Diabetes; 2003 Jun; 4(2):101-9. PubMed ID: 14655266
[TBL] [Abstract][Full Text] [Related]
13. Effects of haemodialysis on circulating endothelial progenitor cell count.
Sturiale A; Coppolino G; Loddo S; Criseo M; Campo S; Crascì E; Bolignano D; Nostro L; Teti D; Buemi M
Blood Purif; 2007; 25(3):242-51. PubMed ID: 17429198
[TBL] [Abstract][Full Text] [Related]
14. Leptin and cardiovascular diseases.
Luo JD; Zhang GS; Chen MS
Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
[TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
Després JP
J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
[TBL] [Abstract][Full Text] [Related]
16. Obesity and osteoarthritis: is leptin the link?
Sandell LJ
Arthritis Rheum; 2009 Oct; 60(10):2858-60. PubMed ID: 19790076
[No Abstract] [Full Text] [Related]
17. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
[TBL] [Abstract][Full Text] [Related]
18. [Leptin as a mediator between obesity and cardiac dysfunction].
Karbowska J; Kochan Z
Postepy Hig Med Dosw (Online); 2012 May; 66():267-74. PubMed ID: 22706112
[TBL] [Abstract][Full Text] [Related]
19. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
Völler H; Schmailzl KJ; Bjarnason-Wehrens B
Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
